Geneseeq Technology Inc., a genetic cancer testing service provider operating in Canada and China, has entered into a global partnership with China-based gene sequencing specialist MGI Tech Co., Ltd (SHA: 688114). The collaboration leverages MGI’s DNBSEQ gene sequencing platform to conduct in-depth cooperation in clinical basic research, product regulatory filing and certification, precision oncology, and early cancer screening and diagnosis, as well as global commercial promotion. Financial details of the partnership were not disclosed.
Company Backgrounds
Geneseeq, founded in 2013, focuses on creating a full-cycle detection system covering companion diagnostics, efficacy monitoring, and early tumor screening. MGI Tech provides core life sciences technologies, including clinical-grade gene sequencers with throughput levels ranging from Gb to Tb.
Partnership Details
The alliance aims to integrate MGI’s advanced gene sequencing platform with Geneseeq’s expertise in oncology testing and diagnostics. This collaboration is expected to enhance the development and commercialization of precision oncology solutions and early cancer screening products globally.-Fineline Info & Tech
Leave a Reply